We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$20.9B
AUM Growth
+$3.23B
(+18%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
19.82%
Holding
593
New
94
Increased
215
Reduced
210
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NOV
NOV
|
+$121M |
| 2 |
NetEase
NTES
|
+$98.7M |
| 3 |
Viatris
VTRS
|
+$94.3M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$85.7M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$85.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$146M |
| 2 |
Meta Platforms (Facebook)
META
|
+$85.3M |
| 3 |
Microsoft
MSFT
|
+$78.2M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$68.7M |
| 5 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.59% |
| 2 | Technology | 13.29% |
| 3 | Financials | 11.96% |
| 4 | Communication Services | 10.26% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Crown Castle
CCI
$32.4B
| $10.1M | 0.05% |
138,856
-12,451
| -8% | -$891K |
|
|
PXD
302
DELISTED
Pioneer Natural Resource Co.
PXD
| $9.93M | 0.05% |
52,600
-44,600
| -46% | -$7.58M |
|
303
Edgewell Personal Care
EPC
$1.28B
| $9.86M | 0.05% |
145,962
-201,671
| -58% | -$14.9M |
|
|
PWRD
304
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
| $9.81M | 0.05% |
492,993
-71,600
| -13% | -$1.45M |
|
|
CIE
305
DELISTED
Cobalt International Energy, Inc
CIE
| $9.8M | 0.05% |
26,286
+16,942
| +181% | +$6.85M |
|
306
Ironwood Pharmaceuticals
IRWD
$644M
| $9.79M | 0.05% |
987,157
| – | – |
|
|
YOKU
307
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $9.77M | 0.05% |
356,394
-186,200
| -34% | -$4.27M |
|
308
SITE Centers
SITC
$232M
| $9.71M | 0.05% |
+479,640
| New | +$10.2M |
|
309
Helix Energy Solutions
HLX
$1.42B
| $9.7M | 0.05% |
382,203
-20,413
| -5% | -$525K |
|
310
State Street
STT
$50.7B
| $9.53M | 0.05% |
145,000
+10,400
| +8% | +$712K |
|
|
PRA
311
DELISTED
ProAssurance
PRA
| $9.32M | 0.04% |
206,800
-48,700
| -19% | -$2.44M |
|
|
PPO
312
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $9.26M | 0.04% |
225,961
+62,710
| +38% | +$2.67M |
|
313
Royal Bank of Canada
RY
$291B
| $9.25M | 0.04% |
144,360
+3,900
| +3% | +$242K |
|
314
CALL
Eli Lilly
LLY
$1.07T
| $9.22M | 0.04% |
+183,200
| New | +$9.59M |
|
|
KZ
315
DELISTED
KongZhong Corporation
KZ
| $9.19M | 0.04% |
701,200
-288,549
| -29% | -$2.86M |
|
|
ALR
316
DELISTED
Alere Inc
ALR
| $9.12M | 0.04% |
+298,159
| New | +$9.08M |
|
317
Moody's
MCO
$84.2B
| $8.97M | 0.04% |
127,500
+9,100
| +8% | +$597K |
|
318
Rockwell Automation
ROK
$51.9B
| $8.96M | 0.04% |
83,802
-26,100
| -24% | -$2.55M |
|
319
NXP Semiconductors
NXPI
$67.6B
| $8.85M | 0.04% |
237,718
-217,866
| -48% | -$7.7M |
|
320
Bio-Techne
TECH
$11.2B
| $8.79M | 0.04% |
+439,200
| New | +$8.33M |
|
321
Melco Resorts & Entertainment
MLCO
$2.18B
| $8.76M | 0.04% |
+275,100
| New | +$7.35M |
|
|
XXIA
322
DELISTED
Ixia
XXIA
| $8.74M | 0.04% |
557,600
+166,100
| +42% | +$2.56M |
|
323
BJ's Restaurants
BJRI
$1.45B
| $8.51M | 0.04% |
+296,323
| New | +$10M |
|
324
American Tower
AMT
$77.7B
| $8.5M | 0.04% |
114,695
-74,758
| -39% | -$5.4M |
|
325
Affiliated Managers Group
AMG
$9.61B
| $8.49M | 0.04% |
46,499
+3,159
| +7% | +$561K |
|
Similar funds
Fidelity International's Q3 2013 Portfolio in Review
As of Q3 2013, Fidelity International held 593 positions worth $20.9B, up 18% from $17.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fidelity International deployed $1.55B of net new capital in Q3 2013, opening 94 new positions and adding to 215 existing holdings. Its largest new stake was Viatris: 2,677,695 shares worth $102M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $146M trimmed.
- Fidelity International's largest Q3 2013 buy was Viatris: 2,677,695 shares worth $102M.
- Fidelity International added most to NOV in Q3 2013, an estimated $121M increase.
- Fidelity International's biggest Q3 2013 reduction was Pfizer, cutting an estimated $146M.
- Fidelity International fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $58.5M.
- Fidelity International's ten largest holdings make up 20% of its $20.9B portfolio in Q3 2013.
- Fidelity International opened 94 new positions and closed 50 in Q3 2013.
- Fidelity International's portfolio value rose 18% quarter-over-quarter to $20.9B.
Based on Fidelity International's 13F filing for Q3 2013, filed 14 Nov 2013.